US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Estrella Immunopharma

0.6596

-0.0134-1.99%

Post-market: 0.65960.00000.00%18:14 EDT

Volume:25.93K

Turnover:17.85K

Market Cap:28.69M

PE:-2.64

High:0.7200

Open:0.6960

Low:0.6596

Close:0.6730

52wk High:3.15

52wk Low:0.5850

Shares:43.50M

Float Shares:14.37M

Volume Ratio:0.52

T/O Rate:0.18%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2502

EPS(LYR):-0.3548

ROE:-268.50%

ROA:-251.86%

PB:-3.86

PE(LYR):-1.86

Loading ...

Overview Company News Filings

Estrella Immunopharma Faces Nasdaq Listing Compliance Challenge

Estrella Immunopharma Risks NASDAQ Delisting After Market Value Falls Below $35 Million Threshold

Estrella Immunopharma Gets NASDAQ Notice After ESLA Bid Price Stays Below $1 for 30 Days

Estrella Immunopharma FY26 Q2 Net Loss Narrows 58.18% to $2.3 Million

Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/Ii Starlight-1 Trial in B-Cell Non-Hodgkin’s Lymphoma

THOMSON REUTERS

Estrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase I/Ii Starlight-1 Trial in B-Cell Non-Hodgkin’s Lymphoma

THOMSON REUTERS

Estrella announces first patient dosed in STARLIGHT-1 Phase I/II trial

Estrella Immunopharma Doses First Patient in Starlight-1 Trial Expansion for EB103 in Relapsed B-cell NHL

Estrella Immunopharma Announces First Patient Dosed in Dose-expansion Phase of Starlight-1 Trial and Reports Durable Response Rate in Advanced B-cell Non-hodgkin’s Lymphoma

THOMSON REUTERS

Estrella Immunopharma Shareholders Ratify 2026 Auditor Appointment

Estrella Immunopharma Holds Annual Stockholders Meeting Via Virtual Webcast

Estrella Immunopharma announces annual shareholder meeting

Estrella Immunopharma Q1 EPS $(0.05) Beats $(0.18) Estimate

Benzinga Earnings

Estrella Immunopharma Q1 net loss widens to $2.3 million from year-ago quarter

Estrella Immunopharma delays quarterly report filing on administrative delay

Estrella Immunopharma to join D. Boral Capital Global Conference investor meetings

Estrella Immunopharma CFO Jiandong Xu buys common shares worth $1,437.8

Estrella Immunopharma FY 2025 net loss widened 48.86% to USD 13.1 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/ESLA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ESLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESLA\",,,,,undefined,":{"symbol":"ESLA","market":"US","secType":"STK","nameCN":"Estrella Immunopharma","latestPrice":0.6596,"timestamp":1789156800000,"preClose":0.673,"halted":0,"volume":25929,"hourTrading":{"tag":"盘后","latestPrice":0.6596,"preClose":0.6596,"latestTime":"18:14 EDT","volume":6,"amount":3.97,"timestamp":1789164879924,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.01991084695393771,"floatShares":14373699,"shares":43497864,"eps":-0.250235,"marketStatus":"Market Closed","change":-0.0134,"latestTime":"09-11 16:00:00 EDT","open":0.696,"high":0.720001,"low":0.6596,"amount":17845.753523400002,"amplitude":0.089749,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.250235,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.673,"postHourTrading":{"tag":"盘后","latestPrice":0.6596,"preClose":0.6596,"latestTime":"18:14 EDT","volume":6,"amount":3.97,"timestamp":1789164879924,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5156962278285145},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESLA\",,,,,undefined,":{"symbol":"ESLA","floatShares":14373699,"roa":"-251.86%","roe":"-268.50%","lyrEps":-0.354786,"volumeRatio":0.5156962278285145,"shares":43497864,"dividePrice":0,"high":0.720001,"amplitude":0.089749,"preClose":0.673,"low":0.6596,"week52Low":0.585,"pbRate":"-3.86","week52High":3.15,"institutionHeld":0,"latestPrice":0.6596,"eps":-0.250235,"divideRate":0,"volume":25929,"delay":0,"ttmEps":-0.250235,"open":0.696,"prevYearClose":1.56,"prevWeekClose":0.6463,"prevMonthClose":0.725,"prevQuarterClose":1.04,"fiveDayClose":0.641,"twentyDayClose":0.7246,"sixtyDayClose":1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ESLA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ESLA","fiscalQuarterEnding":"2026/06","expectedEps":-0.09,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.05},{"date":"2026-05-18","symbol":"ESLA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1779091200000,"name":null,"time":"Pre-MKt","dateTimestamp":1779076800000,"actualEps":null},{"market":"US","date":"2026-03-18","symbol":"ESLA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773806400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-11-12","symbol":"ESLA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2025-08-12","symbol":"ESLA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ESLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ESLA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ESLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ESLA","date":"2026-09-11","current":-2.635922,"percent":0.933709,"low":-10.568666,"twenty":-5.326826,"median":-4.246901,"eighty":-3.374759,"high":-2.273289,"avg":-4.453361,"sd":1.313587,"marketCap":29274062},"quantilePoints":[{"date":"2023-10-13","current":-4.972461,"twenty":-6.796753,"median":-5.384194,"eighty":-5.200498,"marketCap":55265934},{"date":"2023-10-20","current":-4.346628,"twenty":-5.624899,"median":-4.845774,"eighty":-4.503973,"marketCap":48310170},{"date":"2023-10-27","current":-4.814103,"twenty":-5.358857,"median":-4.766595,"eighty":-4.395592,"marketCap":53505872},{"date":"2023-11-03","current":-4.877446,"twenty":-5.358857,"median":-4.877446,"eighty":-4.546793,"marketCap":54209897},{"date":"2023-11-10","current":-4.085653,"twenty":-5.257507,"median":-4.829938,"eighty":-4.367404,"marketCap":45409589},{"date":"2023-11-17","current":-3.800607,"twenty":-5.219501,"median":-4.560729,"eighty":-4.142662,"marketCap":42241478},{"date":"2023-11-24","current":-4.914497,"twenty":-5.067477,"median":-4.560729,"eighty":-4.117325,"marketCap":49633737},{"date":"2023-12-01","current":-5.785861,"twenty":-5.257507,"median":-4.829938,"eighty":-4.244012,"marketCap":58434045},{"date":"2023-12-08","current":-4.18255,"twenty":-5.193333,"median":-4.719087,"eighty":-4.244012,"marketCap":42241478},{"date":"2023-12-15","current":-4.356823,"twenty":-5.067477,"median":-4.653087,"eighty":-4.244012,"marketCap":44001540},{"date":"2023-12-22","current":-4.321969,"twenty":-5.053915,"median":-4.560729,"eighty":-4.244012,"marketCap":43649527},{"date":"2023-12-29","current":-4.008277,"twenty":-5.005043,"median":-4.502348,"eighty":-4.203463,"marketCap":40481416},{"date":"2024-01-05","current":-4.043132,"twenty":-4.967839,"median":-4.461387,"eighty":-4.18255,"marketCap":40833429},{"date":"2024-01-12","current":-3.520313,"twenty":-4.949351,"median":-4.397024,"eighty":-4.086666,"marketCap":35553244},{"date":"2024-01-19","current":-3.555168,"twenty":-4.949351,"median":-4.37517,"eighty":-4.043132,"marketCap":35905256},{"date":"2024-01-26","current":-4.217405,"twenty":-4.914497,"median":-4.391678,"eighty":-4.043132,"marketCap":42593490},{"date":"2024-02-02","current":-4.217405,"twenty":-4.914497,"median":-4.356823,"eighty":-4.022309,"marketCap":42593490},{"date":"2024-02-09","current":-4.008626,"twenty":-4.879642,"median":-4.356475,"eighty":-4.008626,"marketCap":40484936},{"date":"2024-02-16","current":-3.79915,"twenty":-4.877446,"median":-4.314662,"eighty":-4.008277,"marketCap":38369342},{"date":"2024-02-23","current":-4.421106,"twenty":-4.852108,"median":-4.351551,"eighty":-4.008277,"marketCap":36976978},{"date":"2024-03-01","current":-4.46488,"twenty":-4.845774,"median":-4.356823,"eighty":-4.008556,"marketCap":37343087},{"date":"2024-03-08","current":-4.683308,"twenty":-4.845774,"median":-4.37517,"eighty":-4.008626,"marketCap":39169969},{"date":"2024-03-15","current":-4.508653,"twenty":-4.845774,"median":-4.391678,"eighty":-4.019572,"marketCap":37709196},{"date":"2024-03-22","current":-4.727519,"twenty":-4.845774,"median":-4.421106,"eighty":-4.038967,"marketCap":39539739},{"date":"2024-03-28","current":-5.471666,"twenty":-4.878324,"median":-4.421106,"eighty":-4.043132,"marketCap":45763587},{"date":"2024-04-05","current":-4.990159,"twenty":-4.946386,"median":-4.434042,"eighty":-4.068645,"marketCap":41736391},{"date":"2024-04-12","current":-4.771293,"twenty":-4.947572,"median":-4.461387,"eighty":-4.088693,"marketCap":39905848},{"date":"2024-04-19","current":-4.508653,"twenty":-4.946386,"median":-4.46488,"eighty":-4.106683,"marketCap":37709196},{"date":"2024-04-26","current":-4.552426,"twenty":-4.946123,"median":-4.508653,"eighty":-4.135548,"marketCap":38075304},{"date":"2024-05-03","current":-4.604954,"twenty":-4.927077,"median":-4.543309,"eighty":-4.168608,"marketCap":38514635},{"date":"2024-05-10","current":-4.683746,"twenty":-4.914497,"median":-4.525981,"eighty":-4.18255,"marketCap":39173630},{"date":"2024-05-17","current":-6.309978,"twenty":-4.927077,"median":-4.552426,"eighty":-4.18255,"marketCap":38441413},{"date":"2024-05-24","current":-6.009503,"twenty":-4.949351,"median":-4.552645,"eighty":-4.18255,"marketCap":36610870},{"date":"2024-05-31","current":-5.254478,"twenty":-5.016423,"median":-4.56334,"eighty":-4.196492,"marketCap":32011137},{"date":"2024-06-07","current":-5.573329,"twenty":-5.126143,"median":-4.595762,"eighty":-4.217405,"marketCap":33953631},{"date":"2024-06-14","current":-5.672448,"twenty":-5.245388,"median":-4.604954,"eighty":-4.217405,"marketCap":34557478},{"date":"2024-06-21","current":-5.254478,"twenty":-5.254478,"median":-4.639973,"eighty":-4.217405,"marketCap":32011137},{"date":"2024-06-28","current":-5.553028,"twenty":-5.257507,"median":-4.639973,"eighty":-4.217405,"marketCap":33829952},{"date":"2024-07-05","current":-6.836793,"twenty":-5.380881,"median":-4.661859,"eighty":-4.222726,"marketCap":41650855},{"date":"2024-07-12","current":-8.120557,"twenty":-5.46684,"median":-4.674942,"eighty":-4.245731,"marketCap":49471758},{"date":"2024-07-15","current":-8.478817,"twenty":-5.484657,"median":-4.679369,"eighty":-4.24745,"marketCap":51654336},{"date":"2024-08-02","current":-10.568666,"twenty":-5.500483,"median":-4.681339,"eighty":-4.24917,"marketCap":64386038},{"date":"2024-08-09","current":-8.299687,"twenty":-5.526159,"median":-4.683746,"eighty":-4.266453,"marketCap":50563047},{"date":"2024-08-16","current":-8.419107,"twenty":-5.589093,"median":-4.694558,"eighty":-4.282332,"marketCap":51290573},{"date":"2024-08-23","current":-7.881717,"twenty":-5.717813,"median":-4.727519,"eighty":-4.286974,"marketCap":48016706},{"date":"2024-08-30","current":-6.896503,"twenty":-6.017985,"median":-4.738462,"eighty":-4.287114,"marketCap":42014618},{"date":"2024-09-06","current":-6.329258,"twenty":-6.201587,"median":-4.792698,"eighty":-4.288183,"marketCap":38558870},{"date":"2024-09-13","current":-7.045778,"twenty":-6.309738,"median":-4.815066,"eighty":-4.296814,"marketCap":42924025},{"date":"2024-09-20","current":-5.76261,"twenty":-6.309738,"median":-4.815066,"eighty":-4.313201,"marketCap":35106760},{"date":"2024-09-27","current":-5.791271,"twenty":-6.293445,"median":-4.845774,"eighty":-4.331833,"marketCap":35281366},{"date":"2024-10-04","current":-5.494176,"twenty":-6.293445,"median":-4.868142,"eighty":-4.350567,"marketCap":40171894},{"date":"2024-10-11","current":-4.148845,"twenty":-6.216784,"median":-4.858839,"eighty":-4.350567,"marketCap":30335209},{"date":"2024-10-18","current":-4.157755,"twenty":-6.122441,"median":-4.845774,"eighty":-4.288183,"marketCap":30400352},{"date":"2024-10-25","current":-4.212202,"twenty":-6.099645,"median":-4.815066,"eighty":-4.286905,"marketCap":30798452},{"date":"2024-10-31","current":-4.032032,"twenty":-6.085858,"median":-4.815066,"eighty":-4.286835,"marketCap":29481103},{"date":"2024-11-08","current":-3.964716,"twenty":-6.030708,"median":-4.792698,"eighty":-4.245731,"marketCap":28988907},{"date":"2024-11-15","current":-4.157755,"twenty":-6.026467,"median":-4.727519,"eighty":-4.217405,"marketCap":30400352},{"date":"2024-11-22","current":-3.652759,"twenty":-6.001802,"median":-4.723303,"eighty":-4.18255,"marketCap":32209897},{"date":"2024-11-29","current":-4.656782,"twenty":-5.970998,"median":-4.694558,"eighty":-4.18255,"marketCap":41063331},{"date":"2024-12-06","current":-5.005528,"twenty":-5.961427,"median":-4.719087,"eighty":-4.18255,"marketCap":44138559},{"date":"2024-12-13","current":-5.066661,"twenty":-5.907942,"median":-4.727519,"eighty":-4.18255,"marketCap":44677628},{"date":"2024-12-20","current":-4.513181,"twenty":-5.895445,"median":-4.727519,"eighty":-4.18255,"marketCap":39797061},{"date":"2024-12-27","current":-4.800383,"twenty":-5.891211,"median":-4.759354,"eighty":-4.202312,"marketCap":42329601},{"date":"2025-01-03","current":-4.595649,"twenty":-5.831182,"median":-4.759354,"eighty":-4.210222,"marketCap":40524262},{"date":"2025-01-10","current":-4.55421,"twenty":-5.791868,"median":-4.759354,"eighty":-4.214283,"marketCap":40158853},{"date":"2025-01-17","current":-4.808589,"twenty":-5.791868,"median":-4.765324,"eighty":-4.217405,"marketCap":42401960},{"date":"2025-01-24","current":-4.841412,"twenty":-5.791749,"median":-4.765324,"eighty":-4.217405,"marketCap":42691393},{"date":"2025-01-31","current":-4.595239,"twenty":-5.790189,"median":-4.759354,"eighty":-4.217405,"marketCap":40520644},{"date":"2025-02-07","current":-4.718325,"twenty":-5.781211,"median":-4.75438,"eighty":-4.222726,"marketCap":41606019},{"date":"2025-02-14","current":-4.636268,"twenty":-5.75842,"median":-4.727519,"eighty":-4.245731,"marketCap":40882436},{"date":"2025-02-21","current":-6.113309,"twenty":-5.785861,"median":-4.749406,"eighty":-4.252608,"marketCap":53906929},{"date":"2025-02-28","current":-3.938776,"twenty":-5.785861,"median":-4.75438,"eighty":-4.252608,"marketCap":34731981},{"date":"2025-03-07","current":-4.061863,"twenty":-5.76261,"median":-4.727519,"eighty":-4.217405,"marketCap":35817355},{"date":"2025-03-14","current":-4.184949,"twenty":-5.741662,"median":-4.718911,"eighty":-4.212202,"marketCap":36902729},{"date":"2025-03-21","current":-3.781635,"twenty":-5.692164,"median":-4.717095,"eighty":-4.184949,"marketCap":33346319},{"date":"2025-03-28","current":-3.800136,"twenty":-5.672448,"median":-4.683746,"eighty":-4.18255,"marketCap":33646606},{"date":"2025-04-04","current":-3.839558,"twenty":-5.66199,"median":-4.683746,"eighty":-4.157755,"marketCap":33995653},{"date":"2025-04-11","current":-3.717019,"twenty":-5.653341,"median":-4.678332,"eighty":-4.145266,"marketCap":32910685},{"date":"2025-04-17","current":-3.41639,"twenty":-5.652863,"median":-4.673905,"eighty":-4.117991,"marketCap":30248898},{"date":"2025-04-25","current":-3.921251,"twenty":-5.627318,"median":-4.661859,"eighty":-4.100129,"marketCap":34718965},{"date":"2025-05-02","current":-4.656485,"twenty":-5.620962,"median":-4.656633,"eighty":-4.100129,"marketCap":41228771},{"date":"2025-05-09","current":-4.738178,"twenty":-5.614383,"median":-4.656485,"eighty":-4.103875,"marketCap":41952083},{"date":"2025-05-16","current":-3.800286,"twenty":-5.606051,"median":-4.639973,"eighty":-4.100129,"marketCap":33999270},{"date":"2025-05-23","current":-3.448008,"twenty":-5.579539,"median":-4.636268,"eighty":-4.061863,"marketCap":36165589},{"date":"2025-05-30","current":-4.166329,"twenty":-5.561148,"median":-4.636268,"eighty":-4.061535,"marketCap":36888900},{"date":"2025-06-06","current":-4.329714,"twenty":-5.553028,"median":-4.610297,"eighty":-4.04971,"marketCap":38335524},{"date":"2025-06-13","current":-4.125482,"twenty":-5.553028,"median":-4.595762,"eighty":-4.04971,"marketCap":36527244},{"date":"2025-06-20","current":-3.80443,"twenty":-5.54228,"median":-4.595239,"eighty":-4.043395,"marketCap":33684629},{"date":"2025-06-27","current":-3.241128,"twenty":-5.526159,"median":-4.580844,"eighty":-4.026198,"marketCap":33995653},{"date":"2025-07-03","current":-3.034247,"twenty":-5.524015,"median":-4.570132,"eighty":-4.008754,"marketCap":31825718},{"date":"2025-07-11","current":-3.185615,"twenty":-5.515089,"median":-4.55421,"eighty":-4.008277,"marketCap":33413387},{"date":"2025-07-18","current":-2.827711,"twenty":-5.513197,"median":-4.552645,"eighty":-3.966457,"marketCap":29659399},{"date":"2025-07-25","current":-3.273884,"twenty":-5.50782,"median":-4.552426,"eighty":-3.959029,"marketCap":34339226},{"date":"2025-08-01","current":-2.896327,"twenty":-5.494176,"median":-4.538015,"eighty":-3.922458,"marketCap":30379094},{"date":"2025-08-08","current":-2.903223,"twenty":-5.494004,"median":-4.513181,"eighty":-3.885066,"marketCap":30451425},{"date":"2025-08-15","current":-2.639426,"twenty":-5.488988,"median":-4.510917,"eighty":-3.835115,"marketCap":31891232},{"date":"2025-08-22","current":-2.699552,"twenty":-5.46684,"median":-4.508653,"eighty":-3.80035,"marketCap":32617718},{"date":"2025-08-29","current":-2.944966,"twenty":-5.444751,"median":-4.482671,"eighty":-3.7826,"marketCap":35582965},{"date":"2025-09-05","current":-3.313087,"twenty":-5.433608,"median":-4.465996,"eighty":-3.769203,"marketCap":40030836},{"date":"2025-09-12","current":-3.19038,"twenty":-5.427893,"median":-4.461387,"eighty":-3.733631,"marketCap":38548212},{"date":"2025-09-19","current":-3.435793,"twenty":-5.415817,"median":-4.461387,"eighty":-3.662784,"marketCap":41513459},{"date":"2025-09-26","current":-3.527824,"twenty":-5.384194,"median":-4.434042,"eighty":-3.638873,"marketCap":42625427},{"date":"2025-10-03","current":-4.049328,"twenty":-5.384119,"median":-4.421106,"eighty":-3.638873,"marketCap":48926577},{"date":"2025-10-10","current":-3.773237,"twenty":-5.367927,"median":-4.421106,"eighty":-3.650531,"marketCap":45590674},{"date":"2025-10-17","current":-4.940487,"twenty":-5.357776,"median":-4.421106,"eighty":-3.652349,"marketCap":59694131},{"date":"2025-10-24","current":-7.147678,"twenty":-5.384194,"median":-4.430484,"eighty":-3.652759,"marketCap":86362822},{"date":"2025-10-31","current":-7.822566,"twenty":-5.447537,"median":-4.458062,"eighty":-3.652759,"marketCap":94517251},{"date":"2025-11-07","current":-8.466777,"twenty":-5.494176,"median":-4.461387,"eighty":-3.662784,"marketCap":102301025},{"date":"2025-11-14","current":-6.74888,"twenty":-5.526159,"median":-4.46488,"eighty":-3.676173,"marketCap":81544295},{"date":"2025-11-21","current":-4.529504,"twenty":-5.526159,"median":-4.472676,"eighty":-3.681207,"marketCap":61180254},{"date":"2025-11-28","current":-5.899539,"twenty":-5.526159,"median":-4.492666,"eighty":-3.690323,"marketCap":79685392},{"date":"2025-12-05","current":-5.396261,"twenty":-5.526159,"median":-4.508653,"eighty":-3.712136,"marketCap":72887586},{"date":"2025-12-12","current":-5.144622,"twenty":-5.553028,"median":-4.508653,"eighty":-3.730309,"marketCap":69488683},{"date":"2025-12-19","current":-4.417665,"twenty":-5.553028,"median":-4.510917,"eighty":-3.734601,"marketCap":59669630},{"date":"2025-12-26","current":-4.445625,"twenty":-5.536907,"median":-4.508653,"eighty":-3.752515,"marketCap":60047286},{"date":"2026-01-02","current":-4.361745,"twenty":-5.526159,"median":-4.508653,"eighty":-3.764575,"marketCap":58914318},{"date":"2026-01-09","current":-3.970306,"twenty":-5.521871,"median":-4.472676,"eighty":-3.764575,"marketCap":53627136},{"date":"2026-01-16","current":-3.01866,"twenty":-5.514739,"median":-4.46488,"eighty":-3.724653,"marketCap":40773201},{"date":"2026-01-23","current":-2.936814,"twenty":-5.513197,"median":-4.461387,"eighty":-3.683486,"marketCap":39667700},{"date":"2026-01-30","current":-3.360982,"twenty":-5.50782,"median":-4.461387,"eighty":-3.652759,"marketCap":45396966},{"date":"2026-02-06","current":-4.107867,"twenty":-5.494176,"median":-4.445625,"eighty":-3.642957,"marketCap":55485180},{"date":"2026-02-13","current":-3.827785,"twenty":-5.494004,"median":-4.434629,"eighty":-3.650895,"marketCap":51702100},{"date":"2026-02-20","current":-3.827785,"twenty":-5.493318,"median":-4.430484,"eighty":-3.652349,"marketCap":51702100},{"date":"2026-02-27","current":-3.734425,"twenty":-5.471666,"median":-4.421106,"eighty":-3.652759,"marketCap":50441073},{"date":"2026-03-06","current":-3.423223,"twenty":-5.447537,"median":-4.421106,"eighty":-3.641064,"marketCap":46237650},{"date":"2026-03-13","current":-3.890026,"twenty":-5.433608,"median":-4.414536,"eighty":-3.638873,"marketCap":52542785},{"date":"2026-03-20","current":-3.53945,"twenty":-5.427893,"median":-4.391678,"eighty":-3.627157,"marketCap":46237650},{"date":"2026-03-27","current":-3.396624,"twenty":-5.415817,"median":-4.390094,"eighty":-3.590022,"marketCap":44371837},{"date":"2026-04-02","current":-3.429284,"twenty":-5.400172,"median":-4.377333,"eighty":-3.583554,"marketCap":44798489},{"date":"2026-04-10","current":-6.042071,"twenty":-5.429036,"median":-4.390094,"eighty":-3.583554,"marketCap":78930671},{"date":"2026-04-17","current":-5.421534,"twenty":-5.475996,"median":-4.391678,"eighty":-3.587868,"marketCap":70824278},{"date":"2026-04-24","current":-5.584833,"twenty":-5.511722,"median":-4.411407,"eighty":-3.589012,"marketCap":72957539},{"date":"2026-05-01","current":-5.356215,"twenty":-5.497587,"median":-4.419386,"eighty":-3.589853,"marketCap":69970973},{"date":"2026-05-08","current":-4.1478,"twenty":-5.494176,"median":-4.421106,"eighty":-3.592795,"marketCap":54184839},{"date":"2026-05-15","current":-3.935511,"twenty":-5.49349,"median":-4.414536,"eighty":-3.594282,"marketCap":51411599},{"date":"2026-05-22","current":-3.638272,"twenty":-5.488147,"median":-4.391678,"eighty":-3.614779,"marketCap":48211707},{"date":"2026-05-29","current":-3.702214,"twenty":-5.477741,"median":-4.390094,"eighty":-3.623087,"marketCap":49059019},{"date":"2026-06-05","current":-3.73469,"twenty":-5.457189,"median":-4.377333,"eighty":-3.594083,"marketCap":49489362},{"date":"2026-06-12","current":-3.507361,"twenty":-5.43918,"median":-4.361745,"eighty":-3.592102,"marketCap":46476966},{"date":"2026-06-18","current":-3.280032,"twenty":-5.431322,"median":-4.356823,"eighty":-3.586898,"marketCap":43464570},{"date":"2026-06-26","current":-3.085178,"twenty":-5.425349,"median":-4.356649,"eighty":-3.556501,"marketCap":40882516},{"date":"2026-07-02","current":-3.190724,"twenty":-5.420391,"median":-4.353144,"eighty":-3.541409,"marketCap":42281129},{"date":"2026-07-10","current":-3.086477,"twenty":-5.411906,"median":-4.329714,"eighty":-3.521815,"marketCap":40899730},{"date":"2026-07-17","current":-2.410011,"twenty":-5.393848,"median":-4.307696,"eighty":-3.486909,"marketCap":31935700},{"date":"2026-07-24","current":-2.482432,"twenty":-5.384179,"median":-4.306246,"eighty":-3.475283,"marketCap":32895363},{"date":"2026-07-31","current":-2.338565,"twenty":-5.384119,"median":-4.294742,"eighty":-3.454343,"marketCap":30988947},{"date":"2026-08-07","current":-2.422352,"twenty":-5.368427,"median":-4.28845,"eighty":-3.435793,"marketCap":32099230},{"date":"2026-08-14","current":-2.353179,"twenty":-5.367927,"median":-4.286765,"eighty":-3.429284,"marketCap":31182601},{"date":"2026-08-21","current":-3.236472,"twenty":-5.357776,"median":-4.276774,"eighty":-3.407403,"marketCap":32405908},{"date":"2026-08-28","current":-3.13612,"twenty":-5.356215,"median":-4.256749,"eighty":-3.396375,"marketCap":31401108},{"date":"2026-09-04","current":-2.784669,"twenty":-5.339908,"median":-4.248964,"eighty":-3.380772,"marketCap":27882130},{"date":"2026-09-11","current":-2.923686,"twenty":-5.326826,"median":-4.246901,"eighty":-3.374759,"marketCap":29274062}],"updateTime":1789242519767},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ESLA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666308363","title":"Estrella Immunopharma Faces Nasdaq Listing Compliance Challenge","url":"https://stock-news.laohu8.com/highlight/detail?id=2666308363","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666308363?lang=en_us&edition=fundamental","pubTime":"2026-09-09 06:11","pubTimestamp":1788905463,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma ( ($ESLA) ) has issued an update. On September 1, 2026, Estrella Immunopharma received notice from Nasdaq that its market val...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/estrella-immunopharma-faces-nasdaq-listing-compliance-challenge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/estrella-immunopharma-faces-nasdaq-listing-compliance-challenge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCLG","BK4139","ESLA","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666704813","title":"Estrella Immunopharma Risks NASDAQ Delisting After Market Value Falls Below $35 Million Threshold","url":"https://stock-news.laohu8.com/highlight/detail?id=2666704813","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666704813?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:25","pubTimestamp":1788902755,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma risks Nasdaq delisting after market value falls below $35 million thresholdEstrella Immunopharma received a Nasdaq notice for failing the $35 million market value of listed secur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL3WZlWW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290620","title":"Estrella Immunopharma Gets NASDAQ Notice After ESLA Bid Price Stays Below $1 for 30 Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290620","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290620?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:06","pubTimestamp":1787346392,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma gets Nasdaq notice after ESLA bid price stays below $1 for 30 daysEstrella Immunopharma received a Nasdaq notice on Aug. 17, 2026 for failing the $1 minimum bid rule.Shares trade","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLzc38j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160737","title":"Estrella Immunopharma FY26 Q2 Net Loss Narrows 58.18% to $2.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160737","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160737?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:02","pubTimestamp":1786654973,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma FY26 Q2 net loss narrows 58.18% to $2.3 millionEstrella Immunopharma posted a GAAP net loss of USD 2.3 million for the three months ended June 30, 2026, narrowing from USD 5.5 mi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL9D5MGj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997086","title":"Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/Ii Starlight-1 Trial in B-Cell Non-Hodgkin’s Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997086","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997086?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:00","pubTimestamp":1786449603,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA11N5SZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656663376","title":"Estrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase I/Ii Starlight-1 Trial in B-Cell Non-Hodgkin’s Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2656663376","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656663376?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:00","pubTimestamp":1785758402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nTUA6LDHPF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653847480","title":"Estrella announces first patient dosed in STARLIGHT-1 Phase I/II trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2653847480","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653847480?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:05","pubTimestamp":1784894716,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma (ESLA) announced that the first patient has been successfully dosed in the dose-expansion phase of its ongoing STARLIGHT-1 Ph...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/estrella-announces-first-patient-dosed-in-starlight-1-phase-i-ii-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/estrella-announces-first-patient-dosed-in-starlight-1-phase-i-ii-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653084518","title":"Estrella Immunopharma Doses First Patient in Starlight-1 Trial Expansion for EB103 in Relapsed B-cell NHL","url":"https://stock-news.laohu8.com/highlight/detail?id=2653084518","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653084518?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:01","pubTimestamp":1784894485,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma doses first patient in STARLIGHT-1 trial expansion for EB103 in relapsed B-cell NHLEstrella Immunopharma dosed the first patient in the dose-expansion phase of its STARLIGHT-1 Ph","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDL2ySMjz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653084360","title":"Estrella Immunopharma Announces First Patient Dosed in Dose-expansion Phase of Starlight-1 Trial and Reports Durable Response Rate in Advanced B-cell Non-hodgkin’s Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2653084360","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653084360?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:00","pubTimestamp":1784894400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nTUAFTC3T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648560565","title":"Estrella Immunopharma Shareholders Ratify 2026 Auditor Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2648560565","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648560565?lang=en_us&edition=fundamental","pubTime":"2026-07-01 05:54","pubTimestamp":1782856464,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma ( ($ESLA) ) has shared an update. Estrella Immunopharma, Inc. held its combined 2025/2026 Annual Meeting of Stockholders on J...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/estrella-immunopharma-shareholders-ratify-2026-auditor-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/estrella-immunopharma-shareholders-ratify-2026-auditor-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648124567","title":"Estrella Immunopharma Holds Annual Stockholders Meeting Via Virtual Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2648124567","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648124567?lang=en_us&edition=fundamental","pubTime":"2026-07-01 05:30","pubTimestamp":1782855029,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma holds annual stockholders meeting via virtual webcastEstrella Immunopharma held its combined 2025/2026 annual stockholders meeting on June 29, 2026.Shareholders ratified Macias G","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL17D6Cr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638337631","title":"Estrella Immunopharma announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638337631","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638337631?lang=en_us&edition=fundamental","pubTime":"2026-05-28 05:26","pubTimestamp":1779917184,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma will hold its combined 2025/2026 annual shareholder meeting virtually on June 29, 2026.The audit firm reported audit fees of $197,000 for 2025, versus $128,000 for the six-month transition period ended Dec. 31, 2024.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Estrella Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL15Y3zl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636333071","title":"Estrella Immunopharma Q1 EPS $(0.05) Beats $(0.18) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2636333071","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636333071?lang=en_us&edition=fundamental","pubTime":"2026-05-18 21:57","pubTimestamp":1779112631,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma (NASDAQ:ESLA) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.18) by 72.22 percent. This is a 44.44 percent increase over losses of $(0.09) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52634664/estrella-immunopharma-q1-eps-0-05-beats-0-18-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636024806","title":"Estrella Immunopharma Q1 net loss widens to $2.3 million from year-ago quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2636024806","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636024806?lang=en_us&edition=fundamental","pubTime":"2026-05-18 18:05","pubTimestamp":1779098713,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma posted a net loss of approximately $2.3 million for the three months ended March 31, 2026, widening from about $2.1 million a year earlier.Research and development expense edged down to about $1.4 million from roughly $1.41 million in the year-ago quarter.General and administrative costs climbed 28.5% to approximately $0.9 million.Cash and cash equivalents totaled about $1.9 million at March 31, 2026, with a working capital deficit of roughly $6.8 million.STARLIGHT-1 reached 10 patients dosed as of March 31, 2026, with about $8.3 million accrued for outstanding dosing milestone payments to Eureka.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Estrella Immunopharma Inc. published the original content used to gener","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL8QF7wc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636024805","title":"Estrella Immunopharma delays quarterly report filing on administrative delay","url":"https://stock-news.laohu8.com/highlight/detail?id=2636024805","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636024805?lang=en_us&edition=fundamental","pubTime":"2026-05-18 18:04","pubTimestamp":1779098664,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma filed a Form 12b-25 to delay its quarterly report on Form 10-Q for the period ended March 31, 2026.The filing cited an administrative delay in completing the filing process.The company expects to file the Form 10-Q on or before the fifth calendar day following the original due date.It did not expect a significant change in results of operations versus the prior-year period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Estrella Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 18, 2026, and is solely responsible for the information contained ther","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL1zQdYg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633491054","title":"Estrella Immunopharma to join D. Boral Capital Global Conference investor meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2633491054","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633491054?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:02","pubTimestamp":1777982550,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma CEO, CFO set for one-on-one investor meetings at D. Boral Capital 2026 Global Conference on May 7, 2026.Conference scheduled for The Plaza Hotel in New York.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL5ksNf5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631748245","title":"Estrella Immunopharma CFO Jiandong Xu buys common shares worth $1,437.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2631748245","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631748245?lang=en_us&edition=fundamental","pubTime":"2026-04-30 09:37","pubTimestamp":1777513042,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma CFO Xu Jiandong reported open-market purchases of common stock.Direct holdings rose to 265,488 shares following the reported transactions.Spouse-held position increased to 16,700 shares, reported as indirect ownership.Reported purchase prices ranged from $1.04 to $1.33 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Estrella Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL9qXFvS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Estrella Immunopharma CFO Jiandong Xu buys common shares worth $1,437.8","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620317162","title":"Estrella Immunopharma FY 2025 net loss widened 48.86% to USD 13.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620317162","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620317162?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:03","pubTimestamp":1773828237,"startTime":"0","endTime":"0","summary":"Estrella published its annual report on Form 10-K for the fiscal year ended Dec. 31, 2025. The company reported a net loss of USD 13.1 million, compared with a USD 8.8 million net loss a year earlier. Research and development expenses rose 59.9% to USD 10.25 million, driven by higher clinical-phase service fees, seven patient dosings and a second site activation. General and administrative expenses increased 16.7% to USD 2.8 million, primarily due to higher professional fees and stock-based compensation. Estrella ended the year with USD 1.4 million in cash and cash equivalents and a working capital deficit of USD 11.9 million, and management said it expects it will not have sufficient funds to meet working capital requirements and debt obligations starting from one year from the date of the report.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL8SYyPM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}